đź’‰Lasting protection of omicron-specific Covid vaccine could pave way for annual boosters.
Manufacturer Moderna hails data showing jab targeting dominant variant is as effective as initial vaccine but over longer period
https://twitter.com/Telegraph/status/1539676980462985218